Dexcom Inc
DXCM79.850USD
-0.920-1.14%
Horário de mercado （ET）Cotações atrasadas em 15 min
31.31BValor de mercado
58.50P/L TTM
Mais detalhes de Dexcom Inc Empresa
DexCom, Inc. is a medical device company. The Company is primarily focused on the design, development, and commercialization of continuous glucose monitoring (CGM), systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6, Dexcom G7, Stelo, Dexcom Share, and Dexcom ONE. The Company enables people to take control of health through innovative biosensing technology. Dexcom G6 is its integrated continuous glucose monitoring system (iCGM). Stelo is designed specifically for people with type II diabetes who do not use insulin as the first over-the-counter glucose biosensor in the United States. The Dexcom Share remote monitoring system, offered for use with any Dexcom system, uses an app on the patient’s compatible mobile device. Its Dexcom G7 is for adults and children (2+ years) living with type I or type II diabetes who are on any insulin or medications, at risk of hypoglycemia, and those with gestational diabetes.
Informações da empresa
Código da empresaDXCM
Nome da EmpresaDexcom Inc
Data de listagemApr 14, 2005
Fundado em1999
CEOMr. Jacob Steven (Jake) Leach
Número de funcionários10300
Tipo de títulosOrdinary Share
Fim do ano fiscalApr 14
Endereço6340 Sequence Dr
CidadeSAN DIEGO
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal92121
Telefone18582000200
Sitehttps://www.dexcom.com/
Código da empresaDXCM
Data de listagemApr 14, 2005
Fundado em1999
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Jacob Steven (Jake) Leach
Mr. Jacob Steven (Jake) Leach
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
276.26K
+6.52%
Mr. Kevin R. Sayer
Mr. Kevin R. Sayer
Executive Chairman of the Board
Executive Chairman of the Board
233.94K
+11.70%
Mr. Mark G. Foletta
Mr. Mark G. Foletta
Lead Independent Director
Lead Independent Director
62.13K
+4.65%
Mr. Steven R. (Steve) Altman
Mr. Steven R. (Steve) Altman
Independent Director
Independent Director
61.05K
+4.13%
Mr. Richard Alexander Collins
Mr. Richard Alexander Collins
Independent Director
Independent Director
44.38K
+5.82%
Mr. Nicholas (Nick) Augustinos
Mr. Nicholas (Nick) Augustinos
Independent Director
Independent Director
42.13K
+6.12%
Mr. Jereme M. Sylvain
Mr. Jereme M. Sylvain
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
40.15K
+34.41%
Ms. Bridgette P. Heller
Ms. Bridgette P. Heller
Independent Director
Independent Director
28.04K
+21.94%
Mr. Kyle Malady
Mr. Kyle Malady
Independent Director
Independent Director
23.33K
+28.62%
Ms. Rimma Driscoll
Ms. Rimma Driscoll
Independent Director
Independent Director
9.04K
+127.87%
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Jacob Steven (Jake) Leach
Mr. Jacob Steven (Jake) Leach
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
276.26K
+6.52%
Mr. Kevin R. Sayer
Mr. Kevin R. Sayer
Executive Chairman of the Board
Executive Chairman of the Board
233.94K
+11.70%
Mr. Mark G. Foletta
Mr. Mark G. Foletta
Lead Independent Director
Lead Independent Director
62.13K
+4.65%
Mr. Steven R. (Steve) Altman
Mr. Steven R. (Steve) Altman
Independent Director
Independent Director
61.05K
+4.13%
Mr. Richard Alexander Collins
Mr. Richard Alexander Collins
Independent Director
Independent Director
44.38K
+5.82%
Mr. Nicholas (Nick) Augustinos
Mr. Nicholas (Nick) Augustinos
Independent Director
Independent Director
42.13K
+6.12%
Detalhamento da receita
Moeda: USDAtualizado em: dom, 6 de jul
Moeda: USDAtualizado em: dom, 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
Distributor
880.00M
84.94%
Direct
156.00M
15.06%
Por RegiãoUSD
Nome
Receita
Proporção
United States
750.50M
72.44%
Outside of United states
285.50M
27.56%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Distributor
880.00M
84.94%
Direct
156.00M
15.06%
Distribuição de ações
Atualizado em: ter, 20 de mai
Atualizado em: ter, 20 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
The Vanguard Group, Inc.
12.06%
BlackRock Institutional Trust Company, N.A.
6.30%
State Street Global Advisors (US)
4.25%
Baillie Gifford & Co.
3.62%
Capital Research Global Investors
3.07%
Other
70.69%
Investidores
Investidores
Proporção
The Vanguard Group, Inc.
12.06%
BlackRock Institutional Trust Company, N.A.
6.30%
State Street Global Advisors (US)
4.25%
Baillie Gifford & Co.
3.62%
Capital Research Global Investors
3.07%
Other
70.69%
Tipos de investidores
Investidores
Proporção
Investment Advisor
57.41%
Investment Advisor/Hedge Fund
26.61%
Hedge Fund
3.81%
Research Firm
3.68%
Bank and Trust
2.07%
Pension Fund
2.03%
Sovereign Wealth Fund
1.40%
Individual Investor
0.39%
Venture Capital
0.37%
Other
2.25%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
2203
384.61M
98.09%
-26.90M
2025Q1
2252
386.55M
98.59%
-25.17M
2024Q4
2220
380.88M
97.47%
-26.96M
2024Q3
2145
382.31M
97.83%
-30.58M
2024Q2
2115
397.02M
99.11%
-4.31M
2024Q1
2093
389.18M
98.33%
-19.87M
2023Q4
2081
398.01M
103.26%
+83.33K
2023Q3
1994
389.89M
100.89%
-11.88M
2023Q2
1952
389.17M
100.78%
-12.73M
2023Q1
1908
390.83M
100.84%
-11.09M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
The Vanguard Group, Inc.
47.29M
12.06%
+929.54K
+2.01%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
24.72M
6.3%
+538.41K
+2.23%
Mar 31, 2025
State Street Global Advisors (US)
16.68M
4.25%
-3.42K
-0.02%
Mar 31, 2025
Baillie Gifford & Co.
14.18M
3.62%
-432.96K
-2.96%
Mar 31, 2025
Capital Research Global Investors
12.04M
3.07%
-2.34M
-16.25%
Mar 31, 2025
Jennison Associates LLC
10.52M
2.68%
+2.88M
+37.67%
Mar 31, 2025
Sands Capital Management, LLC
10.41M
2.66%
-695.35K
-6.26%
Mar 31, 2025
Geode Capital Management, L.L.C.
10.41M
2.65%
+414.04K
+4.14%
Mar 31, 2025
Invesco Capital Management (QQQ Trust)
8.10M
2.07%
-3.50K
-0.04%
Jun 30, 2025
Nuveen LLC
7.85M
2%
+21.73K
+0.28%
Mar 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: dom, 6 de jul
Atualizado em: dom, 6 de jul
Nome
Proporção
First Trust Nasdaq Lux Digi Health Solutions ETF
7.9%
Global X Internet of Things ETF
6.49%
Langar Global HealthTech ETF
6.24%
Fidelity Digital Health ETF
4.86%
Harbor Health Care ETF
4.22%
Global X HealthTech ETF
4.12%
Touchstone Sands Capital US Select Growth ETF
4.12%
iShares U.S. Medical Devices ETF
3.86%
Motley Fool Mid-Cap Growth ETF
3.67%
Motley Fool Global Opportunities ETF
2.93%
Ver Mais
First Trust Nasdaq Lux Digi Health Solutions ETF
Proporção7.9%
Global X Internet of Things ETF
Proporção6.49%
Langar Global HealthTech ETF
Proporção6.24%
Fidelity Digital Health ETF
Proporção4.86%
Harbor Health Care ETF
Proporção4.22%
Global X HealthTech ETF
Proporção4.12%
Touchstone Sands Capital US Select Growth ETF
Proporção4.12%
iShares U.S. Medical Devices ETF
Proporção3.86%
Motley Fool Mid-Cap Growth ETF
Proporção3.67%
Motley Fool Global Opportunities ETF
Proporção2.93%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Mar 28, 2022
Split
1>4
Data
Tipo
Proporção
Mar 28, 2022
Split
1>4
